PATENT CLAIM ANALYSIS

Application Number: 16104561
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "234500"]

Abstract:
The present invention relates to heterocyclic compounds and methods which may be useful as inhibitors of ATR kinase for the treatment or prevention of cancer.

Claim (Index 14):
The compound as recited in  claim 13 , or a salt thereof, wherein\n Y is selected from C(R 5a ) and N; Z is N; and R 5c  is selected from H and chloro.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 96.0
- Lexical Diversity: 1.04
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16035310', '15990283', '13655164', '15486017', '13547314']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7670536755030358
- 35 USC 102 Novelty (BERT): 0.5629477897988819
- Combined Prediction Score: 0.7466430869326205
- Mean Citation Score: 330.5083120000001
- Max Citation Score: 447.91846
- Similarity Product: 307.48833952681184

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test